正川股份：9月26日召开董事会会议

Group 1 - The core point of the article is that Zhengchuan Co., Ltd. announced the convening of its board meeting to discuss the election of independent directors and other related matters [1] - For the fiscal year 2024, the revenue composition of Zhengchuan Co., Ltd. is heavily weighted towards the pharmaceutical manufacturing sector, accounting for 99.58% of total revenue, with other businesses contributing only 0.42% [1] - As of the report date, Zhengchuan Co., Ltd. has a market capitalization of 3 billion yuan [1] Group 2 - The article mentions a significant growth trend in a new type of insurance product, which has seen a 33-fold increase over five years, indicating a strong market demand [1] - Over 30 insurance companies are entering this market segment, suggesting a competitive landscape and potential investment opportunities [1]